Oculex Pharmaceuticals

About:

Oculex Pharmaceuticals, Inc. operates as a drug delivery and pharmaceutical company.

Top Investors: Notable Capital, Vivo Capital, Aisling Capital, Bay City Capital, Perseus-Soros Biopharmaceutical Fund

Description:

Oculex Pharmaceuticals is an ophthalmic drug delivery company that is focused on the development of therapeutic products for the treatment of sight-threatening diseases. Oculex Pharmaceuticals develops Posurdex, a biodegradable release implant that delivers dexamethasone to the targeted disease site at the back of the eye. Oculex Pharmaceuticals was acquired by Allergan in November 2003. Oculex Pharmaceuticals was founded in 1989 and is based in Sunnyvale, California.

Total Funding Amount:

$50M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

1989-01-01

Founders:

Number of Employees:

101-250

Last Funding Date:

2002-10-22

IPO Status:

Private

Industries: